Authors: Jonkers, IJ de Man, FH van der Laarse, A Frolich, M Leuven, JAG Kamper, AM Blauw, GJ Smelt, AH

Citation: Ij. Jonkers et al., Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia, J HYPERTENS, 19(4), 2001, pp. 749-755

Authors: de Man, FHAF Jonkers, IJAM Schwedhelm, E Smelt, AHM Onkenhout, W van Duyvenvoorde, W Buytenhek, R Leuven, JAG Troost, R van der Laarse, A Princen, HMG

Citation: Fhaf. De Man et al., Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia - Effects of bezafibrate therapy, ART THROM V, 20(11), 2000, pp. 2434-2440

Authors: de Man, FHAF de Beer, F van der Laarse, A Jansen, H Leuven, JAG Souverijn, JHM Vroom, TFFP Schoormans, SCM Fruchart, JC Havekes, LM Smelt, AHM

Citation: Fhaf. De Man et al., The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia ismediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding, ATHEROSCLER, 153(2), 2000, pp. 363-371

Authors: de Man, FH Nieuwland, R van der Laarse, A Romijn, F Smelt, AHM Leuven, JAG Sturk, A

Citation: Fh. De Man et al., Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy, ATHEROSCLER, 152(2), 2000, pp. 407-414

Authors: Kluft, C de Maat, MPM Leuven, JAG van Loon, BJP Mohrschladt, MF

Citation: C. Kluft et al., Statins and C-reactive protein, LANCET, 353(9160), 1999, pp. 1274-1274